Geospatial Analysis of Individual and Community-Level Socioeconomic Factors Impacting SARS-CoV-2 Prevalence and Outcomes SJ Cromer et al, MEDRXIV, September 30, 2020

Hot Topics of the Day|PHGKB

 Coronavirus

Geospatial Analysis of Individual and Community-Level Socioeconomic Factors Impacting SARS-CoV-2 Prevalence and Outcomes
SJ Cromer et al, MEDRXIV, September 30, 2020

Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone
P Fozoumi et al, MEDRXIV September 30, 2020

An integrated clinical and genetic model for predicting risk of severe COVID-19
GS Dite et al, MEDRXIV, September 30, 2020

Ultra-rapid detection of SARS-CoV-2 in public workspace environments
O Yaren et al, MEDRXIV, September 30, 2020

Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State
NF Mueller et al, MEDRXIV, September 30, 2020

Large scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management
AJ Page et al, MEDRXIV< September 30, 2020

Widening the gap: greater racial and ethnic disparities in COVID-19 burden after accounting for missing race/ethnicity data
K Labgold et al, MEDRXIV, September 30, 2020

After bias-adjustment, the magnitude of the absolute racial/ethnic disparity, measured as the difference in infection rates between classified Black and Hispanic persons compared to classified White persons, increased 1.3-fold and 1.6-fold respectively. These results highlight that complete case analyses may underestimate absolute disparities in infection rates.

Alexa, do I have COVID-19?
E AnNthes, Nature News, September 30, 2020

Researchers are exploring ways to use people’s voices to diagnose coronavirus infections, dementia, depression and much more.

Inner Workings: Researchers race to develop in-home testing for COVID-19, a potential game changer.
McDermott Amy et al. Proceedings of the National Academy of Sciences of the United States of America 2020 Sep

Daily rapid testing, even with low-sensitivity tests, could be a useful screening strategy to discreetly identify asymptomatic COVID-19 patients. “What we need is something cheap and fast, that can be rolled out to orders of magnitude more people with regular frequency."